Standard and experimental therapy of cutaneous T-cell lymphoma;Standard- und experimentelle therapie kutaner T-zell-lymphome

Hautarzt

Volumn 54, Issue 12, 2003, Pages 1177-1184

  Beyeler, M ^a   Dummer, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cutaneous T cell lymphoma; Experimental drugs; PUVA; Retinoids

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; ALPHA2A INTERFERON; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; BEXAROTENE; BLEOMYCIN; CHLORAMBUCIL; CHOP PROTOCOL; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; DOXORUBICIN; IMIQUIMOD; ISOTRETINOIN; METHOTREXATE; PEGINTERFERON ALPHA2A; PREDNISONE; RETINOID; STEROID; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG; VINCRISTINE;

ALOPECIA; ARTHRALGIA; ASTHENIA; BLEEDING; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER THERAPY; CHEMOTHERAPY INDUCED EMESIS; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; DRY SKIN; EDEMA; ELECTRON BEAM; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HEADACHE; HISTOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; IMMUNOHISTOLOGY; LEUKOPENIA; MEGAVOLTAGE RADIOTHERAPY; MORTALITY; MUCOSA INFLAMMATION; NAUSEA; PRURITUS; PUVA; RADIATION DOSE; RADIOISOTOPE THERAPY; REVIEW; SKIN ATROPHY; SKIN IRRITATION; SKIN LYMPHOMA; SKIN TUMOR; T CELL LYMPHOMA; THROMBOCYTOPENIA; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; XEROSIS;

ADRENAL CORTEX HORMONES; AMINOQUINOLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHLORAMBUCIL; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; INTERFERON ALFA-2A; LYMPHOMA, T-CELL; METHOTREXATE; PHOTOPHERESIS; PREDNISONE; PUVA THERAPY; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RETINOIDS; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES; VINCRISTINE;

EID: 0346186207     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0630-2     Document Type: Review

References (38)

1. Breneman D, Duvic M, Kuzel T et al. (2002) Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol 138:325-232
2. Bunn PA Jr, Ihde DC, Foon KA (1986) The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer 57:1689-1695
3. Coors EA, von den Driesch P (2000) Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambuciland fluocortolone therapy. Br J Dermatol 143:127-131
4. Dahl MV (2002) Imiquimod: a cytokine inducer. J Am Acad Dermatol 47:S205-208
5. Diederen PV, van Weelden H, Sanders CJ et al. (2003) Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 48:215-219
6. Dummer R, Willers J, Dobbeling U, Burg G (2001) Current pathogenetic aspects of Sezary syndrome and mycosis fungoides. Hautarzt 52:189-192
7. Dummer R, Urosevic M, Kempf W et al. (2003) Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology 207:116-118
8. Duvic M, Cather JC (2000) Emerging new therapies for cutaneous T-cell lymphoma. Dermatol Clin 18:147-156
9. Edelson R, Berger C, Gasparro F et al. (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 316:297-303
10. Fierro MT, Quaglino P, Savoia P et al. (1998) Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP. Leuk Lymphoma 31:583-588
11. Gollnick HP, Owsianowski M, Ramaker J et al. (1995) Extracorporeal photopheresis - a new approach for the treatment of cutaneous T cell lymphomas. Recent Results Cancer Res 139:409-415
12. Hengge UR, Benninghoff B, Ruzicka T, Goos M (2001) Topical immunomodulators - progress towards treating inflammation, infection, and cancer. Lancet Infect Dis 1:189-198
13. Herrmann JJ, Roenigk HH Jr, Hurria A et al. (1995) Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 33:234-242
14. Hofer A, Cerroni L, Kerl H, Wolf P (1999) Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 135:1377-1380
15. Hoppe RT (1991) Total skin electron beam therapy in the management of mycosis fungoides. Front Radiat Ther Oncol 25:80-89; discussion 132-133
16. Jones GW, Hoppe RT, Glatstein E (1995) Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:1057-1076
17. Kessler JF, Jones SE, Levine N et al. (1987) Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides). Arch Dermatol 123:201-204
18. Knobler R, Girardi M (2001) Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Ann N Y Acad Sci 941:123-138
19. Knobler E, Warmuth I, Cocco C et al. (2002) Extracorporeal photochemotherapy - the Columbia Presbyterian experience. Photodermatol Photoimmunol Photomed 18:232-237
20. Kontochristopoulos GJ, Exadaktylou D, Hatziolou E et al. (2001) Follicular mudnosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon alpha-2b and acitretin. J Dermatolog Treat 12:117-121
21. Molineux G (2002) Pegylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat Rev 28 [Suppl A]:13-16
22. Olsen EA, Bunn PA (1995) Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:1089-1107
23. Olsen EA, Rosen ST, Vollmer RT et al. (1989) Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 20:395-407
24. Ong C, Sullivan J, Hertzberg M, Stapleton K (2002) Stage IV CD30+ anaplastic large cell lymphoma: response to acitretin and interferon-alpha. Australas J Dermatol 43:207-210
25. Rosen ST, Foss FM (1995) Chemotherapy for mycosis fungoides and the Sezary syndrome. Hematol Oncol Clin North Am 9:1109-1116
26. Sentis HJ, Willemze R, Van Vloten WA (1985) Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients. Acta Derm Venereol 65:179-183
27. Sinha AA, Heald P (1998) Advances in the management of cutaneous T-cell lymphoma. Dermatol Clin 16:301-311
28. Stadler R, Otte HG (1995) Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy. Recent Results Cancer Res 139:391-401
29. Stanley MA (2002) Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27:571-577
30. Thomsen K, Molin L, Volden G et al.(1984) 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol 64:563-566
31. Voss N, Kim Sing C (1998) Radiotherapy in the treatment of dermatologic malignancies. Dermatol Clin 16:313-320
32. Winkelmann RK, Diaz-Perez JL, Buechner SA (1984) The treatment of Sezary syndrome. J Am Acad Dermatol 10:1000-1004
33. Wiskemann A, Buck C (1978) Radiotherapy of mycosis fungoides: twenty years of experience with teleroentgen and low-voltage X-ray therapy. J Dermatol Surg Oncol 4:606-610
34. Wolff JM, Zitelli JA, Rabin BS et al. (1985) Intralesional interferon in the treatment of early mycosis fungoides. J Am Acad Dermatol 13:604-612
35. Wollina U, Graefe T, Karte K (2000) Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin. J Am Acad Dermatol 42:40-46
36. Zackheim HS, Epstein EH Jr (1989) Low-dose methotrexate for the Sezary syndrome. J Am Acad Dermatol 21:757-762
37. Zackheim HS, Kashani-Sabet M, Hwang ST (1996) Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients. J Am Acad Dermatol 34:626-631
38. Zackheim HS, Kashani-Sabet M, Amin S (1998) Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol 134:949-954